Advance Publication. Atherosclerotic Component of the Yellow Segment After Drug-Eluting Stent Implantation on Coronary Angioscopy
|
|
- Allison Lawson
- 5 years ago
- Views:
Transcription
1 Circulation Journal doi: /circj.CJ ORIGINAL ARTICLE Imaging Atherosclerotic Component of the Yellow Segment After Drug-Eluting Stent Implantation on Coronary Angioscopy An Ex-Vivo Validation Study Masahiko Shibuya, MD; Kenichi Fujii, MD; Hiroyuki Hao, MD; Takahiro Imanaka, MD; Ten Saita, MD; Rika Kawakami, MD; Kojiro Miki, MD; Hiroto Tamaru, MD; Tetsuo Horimatsu, MD; Akinori Sumiyoshi, MD; Machiko Nishimura, MD; Seiichi Hirota, MD; Tohru Masuyama, MD; Masaharu Ishihara, MD Background: Coronary angioscopy (CAS) is used to comprehensively evaluate vascular responses after drug-eluting stent (DES) implantation. This study sought to evaluate the capability of CAS for evaluating DES strut coverage grade and color grade of the intima compared with histological images in coronary autopsy specimens. Methods and Results: A total of 23 DES extracted from 11 autopsy hearts were imaged by CAS. All stent segments were graded as white or yellow according to the luminal surface color, and thrombus was evaluated according to a previous report. Neointimal coverage over the DES was graded as 0 (stent struts fully visible) to grade 3 (stent struts fully embedded and invisible). Of 76 segments, neointimal coverage was graded as 0 in 35 (46%), 1 in 22 (29%), 2 in 8 (11%), and 3 in 11 (14%). The neointimal thickness increased significantly with increasing neointimal coverage grade on angioscopy. Neointimal color was graded as white in 40 (53%) and yellow in 36 segments (47%). Histological analysis revealed that yellow neointima contained fibroatheroma, foam cells accumulation or superficial calcium deposition. A thrombus was identified in 13 segments. Thrombi adherent around the stent strut were partly intimal erythrocyte accumulation around the strut. Conclusions: In-stent yellow segment had atherosclerotic components. CAS could evaluate vascular status comprehensively after DES implantation. Key Words: Atherosclerosis; Coronary angioscopy; Vulnerable plaque Coronary angioscopy (CAS) involves direct visualization of the color and superficial morphology of plaque and thrombus, using projected white light through thin, flexible glass fibers loaded into catheters. Several studies have shown that CAS identifies atherosclerosis as yellow-colored plaques, which have been regarded as high-risk plaques and correlated with future coronary events. 1,2 CAS has also been used after drug-eluting stent (DES) implantation, because of its ability to comprehensively evaluate vascular responses, including the degree of neointimal coverage, with intimal color detected as yellow or white. 3,4 A prospective study has revealed that a yellow intima after DES implantation is significantly associated with a higher risk of thrombus formation and target lesion revascularization, as assessed during long-term follow-up. 5 Therefore, the presence of yellow intima after DES implantation has been considered as a surrogate marker of risk of DES failure. Furthermore, CAS is suitable for evaluating the degree of neointimal coverage after DES implantation. 3 A previous study has revealed that incomplete neointimal coverage after DES implantation assessed by CAS was associated with subclinical thrombus formation; 6 however, to date, a validation study comparing CAS findings to histological findings after DES implantation has not been carried out. Therefore, in the present study, we assessed the capability of CAS for evaluating DES strut coverage grade and color grade of the intima, compared with histological images after DES implantation in coronary autopsy specimens. Methods Study Subjects and Tissue Excision A total of 23 DES (7 sirolimus-eluting stents [SES], 4 Received June 12, 2018; revised manuscript received August 12, 2018; accepted October 9, 2018; J-STAGE released online November 2, 2018 Time for primary review: 42 days Division of Cardiovascular Medicine and Coronary Heart Disease (M.S., T.I., T.S., K.M., H.T., T.H., A.S., M.N., T.M., M.I.), Department of Surgical Pathology (K.F., R.K., S.H.), Hyogo College of Medicine, Nishinomiya; Department of Pathology, Nihon University School of Medicine, Tokyo (H.H.), Japan Mailing address: Kenichi Fujii, MD, Department of Surgical Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya , Japan. kfujii350@hotmail.com ISSN All rights are reserved to the Japanese Circulation Society. For permissions, please cj@j-circ.or.jp
2 2 SHIBUYA M et al. Table. Profiles of the Study Subjects and the Implanted Drug-Eluting Stents Patient no. Cause of death Vessel Stent diameter (mm) length (mm) Implant duration (months) Neoatherosclerosis 1 Pneumonia RCA EES (3 18) 2 Foam cells LAD SES (3 23) 2 None LCX EES (2.5 8) 2 None 2 Infective endocarditis LAD SES (3 28) 45 Calcification 3 Sepsis RCA SES (3.0 18) 61 None RCA EES (3.0 15) 28 None RCA PES (3.0 12) 43 Foam cells, fibroatheroma LAD SES (3.5 23) 61 Foam cells, fibroatheroma LAD SES (3.0 18) 61 Foam cells 4 AMI, cardiac tamponade RCA EES (3.5 15) 1 None RCA EES (3.5 18) 1 None 5 Thoracic aortic dissection RCA EES (2.5 20) 7 Foam cells LAD EES (2.5 38) 7 None 6 Congestive heart failure, LAD SES (3.5 28) 5 None ischemic cardiomyopathy 7 Thoracic aortic rupture RCA EES (2.5 12) 17 Foam cells 8 Thoracic aortic aneurysm RCA EES (3.0 18) 4 None LCX EES (2.5 28) 4 None 9 Ventricular fibrillation RCA PES (3.0 32) 69 Calcification RCA PES (3.0 16) 69 Fibroatheroma, calcification 10 Unknown RCA EES (3.5 28) 20 None LAD EES ( ) 29 Calcification 11 AMI LAD PES ( ) 35 None LCX SES (2.5 13) 35 None AMI, acute myocardial infarction; EES, everolimus-eluting stent; LAD, left anterior descending; LCX, left circumflex artery; PES, paclitaxel-eluting stent; RCA, right coronary artery; SES, sirolimus-eluting stent. inations were performed. The time interval between death and CAS examination did not exceed 12 h. The experimental and ex-vivo study protocols were approved by the Institutional Review Board of Hyogo College of Medicine, and written informed consent was obtained from the patients relatives in all cases. Figure 1. Relationship between the angioscopic coverage grade and the neointimal thickness measured by histology. The neointimal thickness increased significantly as the neointimal coverage assessed by CAS increased. Range of the fibrous cap thickness was: grade 0 (n=35): 15±21 µm, grade 1 (n=22): 122±125 µm, grade 2 (n=8): 304±296 µm, and grade 3 (n=11): 540±362 µm; P< CAS, coronary angioscopy. paclitaxel-eluting stents [PES], and 12 everolimus-eluting stents [EES]) with implant durations of 1 69 (median 24) months taken from 11 cadavers were examined. All stented coronary arteries were dissected at autopsy within 6 h of death. Harvested coronary arteries were immediately stored in phosphate-buffered saline and subsequently, CAS exam- CAS Imaging Procedure and Analysis CAS images were obtained using a 4.5F angioscopic catheter (Vecmova; FiberTech, Tokyo, Japan). The white balance was initially adjusted for color correction. The light power was adjusted to gain appropriately bright colored images without reflection. The coronary arteries were observed with simultaneous distal 0.9% saline flush delivery, in order to remove blood cells from the imaging field. CAS catheter was introduced and manually pulled back to identify the stent segment. All segments were graded as white or yellow according to the luminal surface color in a manner similar to that adopted in earlier reports. 4 Thrombus was defined as a coalescent, red superficial or protruding mass, adhering to the vessel surface, based on the criteria of the European Working Group on Coronary Angioscopy. 7 Neointimal coverage over the DES was classified into 4 grades: grade 0=stent struts fully visible; grade 1=stent struts bulging into the lumen and still transparently visible; grade 2=stent struts embedded into the neointima but seen translucently; grade 3=stent struts fully embedded and invisible on angioscopy. 3,8 Histological Study After CAS examination, the stented segments were fixed in
3 Yellow Segment After DES Implantation 3 Figure 2. Representative images on coronary angioscopy (CAS) and corresponding histology. (Left) Angioscopic images, (Middle & Right) corresponding histological images. In the angioscopic images, the color of each segment was graded as yellow (A,D,G) or white (J). (A) CAS image of light-yellow segment with grade 3 intimal coverage. (B) Corresponding histological image of the lesion in (A) showing eccentric proliferation of the neointima (H&E, scale bar=500 µm). (C) Magnified image of the inset in (B) showing many foam cells accumulating on the luminal surface (H&E, scale bar=200 µm). (D) CAS image shows an intenseyellow segment covered with grade 3 intima. (E) Corresponding cross-sectional histological image of the lesion in (D) shows a fibrous cap overlying a large, lipid-rich necrotic core within the stent (H&E, scale bar=1 mm). (F). Higher magnification of the neointima within the stent struts shows lymph cells infiltrating around stent strut. *Stent strut. (H&E, scale bar=500 μm.) (G) CAS image of an intense-yellow segment with a sharp border and intimal coverage of grade 2. (H) Histological image of the same section of the lesion in (G) (H&E, scale bar=1 mm). (I) Magnified image of the inset in (H) showing sheet calcification in the neointima between stent struts (*) (H&E, scale bar=100 µm). (J) CAS image of a white segment with grade 3intimal coverage. (K) Corresponding histological image of the lesion in (J) showing neointima proliferation on all stent struts (H&E, scale bar=500 µm). (L) Magnified image of the inset in (K) showing stable, homogeneous fibrous tissue without lipid deposition (H&E, scale bar=200 µm). 10% neutral buffered formalin for 48 h, then embedded in methyl methacrylate. Histological cross-sections were sliced 5-μm thick, at approximately 3 4 mm intervals, using a diamond blade. Each slice was stained with hematoxylin and eosin, Masson s trichrome, and elastica van Gieson stain. Histological analysis was based on evaluation by a single pathologist (H.H.), who was blinded to the imaging results. Neoatherosclerosis was defined as fibroatheroma, foam cell accumulation, and superficial calcium deposition in the intima. A thrombus was defined as an organized collection of fibrin and erythrocytes in the lumen as illus- trated by Lammie et al. 9 Statistical Analysis Continuous data were tested by 1-way analysis of variance of the different categories (coverage grade), and the Mann-Whitney test was performed in cases of a significant difference. The incidence of calcification was compared among the groups using the chi-square test or Fisher s exact test. All tests were performed using JMP10 (SAS Institute, Cary, NC, USA).
4 4 SHIBUYA M et al. sclerosis on CAS, the sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy for neoatherosclerosis were 96%, 76%, 67%, 98%, and 83%, respectively. Based on the histological analysis, false-positive diagnoses of CAS for neoatherosclerosis comprised neointima of low coverage grade (grade 0: n=8, grade 1: n=3, grade 2: n=1) with underlying plaque morphology of lipid-rich fibroatheroma or calcified plaque. Color grading of the neointima was affected by tissue morphology behind the stent strut when the neointimal coverage was sparse. Thrombus on Angioscopy and Histology Although thrombus was observed in 13 segments (17%) by CAS, histopathological analysis identified thrombus in only 5 segments; the other 8 segments contained intraplaque erythrocyte accumulation without fibrin around the stent strut (Figure 3). Figure 3. (A) Coronary angioscopy (CAS) image of a dark yellow-red segment distributed around a stent strut with grade 1 intimal coverage. (B) Corresponding histological image from the same section of the lesion in (A) showing sheet calcification underneath the stent strut. Neointimal proliferation is sparse (H&E, scale bar=1 mm). (C,D) Magnified image of the inset in (B) showing red blood cells around the stent strut (*) inside the neointima (H&E, scale bar=100 µm). Results A total of 80 histological segments were obtained for 23 DES. After co-registration of the segments and CAS imaging, 4 histological segments were excluded because of cutting artifacts (n=2) or co-registration difficulty (n=2). DES profiles are listed in the Table. CAS demonstrated neointimal coverage as grade 0 (n=35, 46%), grade 1 (n=22, 29%), grade 2 (n=8, 11%), and grade 3 (n=11, 14%). Neointimal color was graded as white in 40 segments (53%) and yellow in the remaining 36 segments (47%). A thrombus was identified in 13segments by CAS. Neointimal Coverage Grade The relationship between neointimal coverage grade and neointimal thickness obtained by histology is shown in Figure 1. The median intimal thickness by histology of grades 0 3 was, respectively, 6 µm (interquartile range [IQR], 0 20 µm), 89 µm (IQR, µm), 202 µm (IQR, µm), and 429 μm (IQR, μm; P<0.001). Neointimal thickness increased significantly with increasing neointimal coverage grade on angioscopy. The neointimal thickness was significantly larger in yellow intima than in white intima (170±294 µm vs. 132±200 µm, P=0.05). Neointimal Color Grade Histological analysis revealed that segments classified as yellow by CAS contained neoatherosclerotic components such as fibroatheroma (4 segments, 3 DES), foam cell accumulation (11 segments, 6 DES), or superficial calcium deposition (11 segments, 4 DES) within the neointima. In contrast, segments classified as white were composed of smooth muscle cells with extracellular matrix and collagen fibers. These features as recognized by CAS and corresponding histology are listed in Figure 2. When a yellow segment was considered to be neoathero- Incidence of Neoatherosclerosis The prevalence of foam cell accumulation was 29%, 25%, and 25%, calcification was 14%, 50%, and 8%, and fibroatheroma was 14%, 50%, and 0% in SES, PES, and EES, respectively. No significant difference was identified for each finding among the 3 DES. Discussion The main findings of the present study were as follows. (1) Neointimal thickness increased significantly as neointimal coverage grade increased on angioscopy. (2) Histological analysis revealed that yellow neointima after DES implantation contained atherosclerotic components, including fibroatheroma, foam cell accumulation and superficial calcium deposition. (3) When intimal coverage was sparse, the yellow segments reflected fibroatheroma formation underneath the stent. (4) Thrombi adherent around the stent strut on CAS were often intimal erythrocyte accumulation on histology. In native coronary arteries, yellow plaques are often observed as culprit lesions in acute coronary syndrome (ACS) patients, and are considered as vulnerable plaques that may lead to ACS events. 1,2 Our ex-vivo study demonstrated dark-yellow plaques on CAS, including fibroatheroma formation with high sensitivity. On the other hand, white plaques, including fibrous plaques or thick fibrous caps, are considered as stable. 10 Thus, the varying color of plaques reflects the internal components and the degree of plaque vulnerability. CAS has also shown that there are 2 neointimal colors after coronary stent implantation: white and yellow. A prospective clinical study revealed that yellow intima after DES implantation significantly correlated with a higher risk of thrombus formation and target lesion revascularization during long-term follow-up. 5 Therefore, yellow neointima could contain thrombogenic components such as a necrotic core. A previous pathological study demonstrated that the prevalence of neoatherosclerosis was higher after DES implantation, as compared with bare metal stent implantation. 11 Neoatherosclerosis is considered to be one of the mechanisms leading to stent thrombosis after DES implantation. In fact, it has been reported that rupture of yellow plaques within the stented segment was detected by CAS, in lesions with late or very late stent thrombosis after DES implantation. 12 In line with these
5 Yellow Segment After DES Implantation 5 findings, we previously demonstrated ex vivo that of an intensive yellow segment after DES implantation on CAS imaging represented a large lipid-rich necrotic core, covered with a thin fibrous cap infiltrated by lipid-laden macrophages, with few smooth muscle cells on histology. 13 Similarly, in the present study, yellow segments after DES implantation included neoatherosclerosis. In segments with a yellow neointima, the main tissue components were fibroatheroma, macrophage accumulation, and calcification. We previously demonstrated that calcification has several angioscopic color grades, and some superficial calcium plates appeared yellow on CAS in an ex-vivo histopathological validation study. 10 Although the precise mechanism of the calcification after stent implantation has not been elucidated, a previous pathological study reported deposition of calcium within the intima after 1st-generation DES implantation. 14 In our previous an ex-vivo imaging study, most superficial calcium deposits had a sharp border and most fibroatheroma had a diffuse border. 10 In our current study, when yellow intima had a sharply defined border on CAS, it contained superficial intimal calcium deposition with high diagnostic accuracy (Figure 2G). This finding means it is possible to differentiate superficial calcium deposition from fibroatheroma and foam cell accumulation. In the current ex-vivo study, the color of the neointima was affected by underlying tissue morphology behind the stent strut when the neointimal coverage was sparse. Therefore, careful interpretation is required to evaluate yellow neointimal color grade by CAS, especially in the presence of visible stent strut. Thrombus appearance around the stent strut on CAS was often intimal erythrocyte accumulation without intraluminal fibrin accumulation as evaluated by histology, reflecting intimal hemorrhage or thrombus absorption adherent to the stent strut. The eluted drug may affect delayed stent healing resulting in the thrombus remaining for longer. Plaque hemorrhage is an important mechanism of plaque progression in native coronary arteries, especially in advanced coronary atherosclerosis. 15 Carotid plaque hemorrhage by magnetic resonance imaging predicts cerebrovascular events. 16 In the present study, intimal erythrocyte accumulation was covered with fibrous tissue and endothelial cells, which may not directly lead to late stent thrombosis, but may be a cause of late stent restenosis or neoatherosclerosis in the future. Study Limitations First, a positional discrepancy in the evaluated crosssections between the angioscopic and histological images may have influenced the results, although we took care to achieve optimal co-registration of the images. Second, the color of the segments was determined unaided visually, and therefore was quite subjective. Third, the angioscopic images were taken in cadaver hearts, which may have affected the results. Fourth, we did not perform any immunochemical staining to identify macrophages. Conclusions In-stent yellow segments had atherosclerotic components, such as fibroatheroma formation, foam cell accumulation, and superficial calcium deposition. Furthermore, the yellow color reflected vulnerable components underneath the stent when neointimal coverage was sparse. CAS can comprehensively evaluate vascular status after DES implantation. Acknowledgments The authors thank the staff in the Department of Surgical Pathology at Hyogo College of Medicine for their excellent assistance with the study. None. Grants References 1. Mizuno K, Miyamoto A, Satomura K, Kurita A, Sakurada M, Yanagida S, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337: Takano M, Jang IK, Inami S, Yamamoto M, Murakami D, Okamatsu K, et al. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 2008; 101: Awata M, Uematsu M, Sera F, Ishihara T, Watanabe T, Fujita M, et al. Angioscopic assessment of arterial repair following biodegradable polymer-coated Biolimus A9-eluting stent implantation. Circ J 2011; 75: Dai K, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Miura F, et al. Coronary angioscopic findings 9 months after everolimuseluting stent implantation compared with sirolimus-eluting stents. J Cardiol 2013; 61: Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T, et al. In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy). JACC Cardiovasc Interv 2015; 8: Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents. J Am Coll Cardiol 2006; 47: Den Heijer P, Foley DP, Hillege HL, Lablanche JM, van Dijk RB, Franzen D, et al. The Ermenonville classification of observations at coronary angioscopy: Evaluation of intra- and interobserver agreement. Eur Heart J 1994; 15: Awata M, Kotani JI, Uematsu M, Morozumi T, Watanabe T, Ohnishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. Circulation 2007; 116: Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries: Relevance of the unstable atherosclerotic plaque. Stroke 1999; 30: Shibuya M, Fujii K, Hao H, Imanaka T, Fukunaga M, Miki K, et al. Ex vivo comparison of angioscopy and histopathology for the evaluation of coronary plaque characteristics. Int J Cardiovasc Imaging 2016; 32: Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting-stents. JACC Cardiovasc Imaging 2009; 2: Ikenaga H, Ishihara M, Dai K, Nakama Y, Ohtani T. Mechanisms of very late stent thrombosis after drug-eluting stent implantation. JACC Cardiovasc Imaging 2011; 4: Fujii K, Hao H, Imanaka T, Kawano T, Takayama T, Hirayama A, et al. In-stent thin-cap fibroatheroma after drug-eluting stent implantation. JACC Cardiovasc Interv 2014; 7: Otsuka F, Vorpahl M, Nakano M, Forest J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimuseluting stents versus first-generation sirolimus- and paclitaxeleluting stents in humans. Circulation 2014; 129: Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: Saam T, Hetterich H, Hoffmann V, Yuan C, Dichgans M, Poppert H, et al. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013; 62:
2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:
Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS
More informationOCT; Comparative Imaging Results with IVUS, VH and Angioscopy
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy
More information1830 MIYOSHI T et al. Circ J 2018; 82: ORIGINAL ARTICLE doi: /circj.CJ
1830 MIYOSHI T et al. Circ J 2018; 82: 1830 1835 ORIGINAL ARTICLE doi: 10.1253/circj.CJ-17-1396 Imaging Assessment of Second- and Third-Generation Drug-Eluting Stents on Chronic Coronary Angioscopy Multicenter
More informationCatch-up Phenomenon: Insights from Pathology
Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re
More informationWhat Does the Yellow Color of Angioscopy Mean? Why Yellow Plaque Is Always Vulnerable?
Review Angioscopy 2017; 3: 9 18 What Does the Yellow Color of Angioscopy Mean? Why Yellow Plaque Is Always Vulnerable? Kyoichi Mizuno, MD, PhD, *1 and Masamichi Takano, MD, PhD 2 1 Mitsukoshi Health and
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationPathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005
Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque
More informationas a Mechanism of Stent Failure
In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I
More informationAppearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents
Journal of the American College of Cardiology Vol. 55, No. 1, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.08.032
More informationDrug eluting stents (DES) have decreased
JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 11, 1 1 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jcmg.1.. BRIEF REPORT OCT-Verified
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationAnalysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent
Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent implantation. Department of Cardiology, Ehime Prefectural Imabari
More informationOptical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent
Optical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent heart institute, Division of cardiology, Tokyo, Japan Yusuke Watanabe, Ryuta Asano,
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationReview Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
ombosis Volume 2012, Article ID 608593, 16 pages doi:10.1155/2012/608593 Review Article Pathologic Etiologies of Late and Very Late Stent ombosis following First-Generation Drug-Eluting Stent Placement
More informationOCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis?
OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research
More informationCLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus
CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT
More informationInvasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationImaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationInsights in Thrombosis and In-Stent Restenosis
Clinical Value of OCT Insights in Thrombosis and In-Stent Restenosis Fernando Alfonso MD, PhD, FESC Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Madrid.
More informationOptical Coherence Tomography
Optical Coherence Tomography Disclosure Information Demetrius Lopes MD The following relationships exist related to this presentation: University Grant/Research Support: Rush University Industry Grant
More informationClinical Investigations
Clinical Investigations Serial Angioscopic Evaluation of Neointimal Coverage and Incidence of Thrombus Formation After Paclitaxel-Eluting Stent Implantation: Comparison Between 6- and 18-Month Follow-Up
More informationSites of Atherosclerosis In order of Frequency
Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary
More informationPathology of Cardiovascular Interventions. Body and Disease 2011
Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent
More informationChanges in Coronary Plaque Color and Morphology by Lipid-Lowering Therapy With Atorvastatin: Serial Evaluation by Coronary Angioscopy
Journal of the American College of Cardiology Vol. 42, No. 4, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00770-8
More informationState of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC
State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical
More informationOCT. molecular imaging J Jpn Coll Angiol, 2008, 48: molecular imaging MRI positron-emission tomography PET IMT
48 6 CT MRI PET OCT molecular imaging J Jpn Coll Angiol, 2008, 48: 456 461 atherosclerosis, imaging gold standard computed tomography CT magnetic resonance imaging MRI CT B intima media thickness IMT B
More informationResearch Article Pathological Perspective of Drug-Eluting Stent Thrombosis
Thrombosis Volume 2012, Article ID 219389, 8 pages doi:10.1155/2012/219389 Research Article Pathological Perspective of Drug-Eluting Stent Thrombosis Katsumi Inoue Department of Laboratory Medicine, Kokura
More informationChapter 43 Noninvasive Coronary Plaque Imaging
hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate
More informationTVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology
TVA_C2.qxd 8/8/6 :27 AM Page 19 2 PART 2 Pathology TVA_C2.qxd 8/8/6 :27 AM Page TVA_C2.qxd 8/8/6 :27 AM Page 21 2 CHAPTER 2 The pathology of vulnerable plaque Renu Virmani, Allen P Burke, James T Willerson,
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationOptical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents J-S Kim, 1 I-K Jang, 2 J-S Kim, 1 T H Kim, 1 M Takano, 3 T Kume, 4 N
More informationPathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans
Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans Fumiyuki Otsuka, MD, PhD; Marc Vorpahl, MD; Masataka Nakano, MD; Jason
More informationOCT Findings: Lesson from Stable vs Unstable Plaques
ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston
More informationReview Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes
SAGE-Hindawi Access to Research Cardiology Research and Practice Volume 2011, Article ID 312978, 7 pages doi:10.4061/2011/312978 Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationAngioscopic Comparison of Resolute and Endeavor Zotarolimus-Eluting Stents
650 NISHIMOTO Y et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Cardiovascular Intervention Angioscopic Comparison of Resolute and
More informationNeointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography
Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography B X Chen, F Y Ma, W Luo, J H Ruan, W L Xie, X Z Zhao, S H Sun, X M Guo, F Wang, T Tian, X W Chu
More informationUsefulness of OCT during coronary intervention
Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization
More informationPathology of the Vulnerable Plaque
Journal of the American College of Cardiology Vol. 47, No. 8 Suppl C 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.065
More informationThe Pathology of Neoatherosclerosis in Human Coronary Implants
Journal of the American College of Cardiology Vol. 57, No. 11, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.011
More informationQuantitative Imaging of Transmural Vasa Vasorum Distribution in Aortas of ApoE -/- /LDL -/- Double Knockout Mice using Nano-CT
Quantitative Imaging of Transmural Vasa Vasorum Distribution in Aortas of ApoE -/- /LDL -/- Double Knockout Mice using Nano-CT M. Kampschulte 1, M.D.; A. Brinkmann 1, M.D.; P. Stieger 4, M.D.; D.G. Sedding
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationActa Cardiol Sin 2018;34: doi: /ACS _34(2) A
Original Article Acta Cardiol Sin 2018;34:124 129 doi: 10.6515/ACS.201803_34(2).20171115A Coronary Artery Disease Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary
More informationPlaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD
Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant
More informationMorphological changes after percutaneous transluminal coronary angioplasty of unstable plaques
European Heart Journal (1996) 17, 1554-1559 orphological changes after percutaneous transluminal coronary angioplasty of unstable plaques Insights from serial angioscopic follow-up C. Bauters, J.-. Lablanche,
More informationAssessment of Culprit Lesion Morphology in Acute Myocardial Infarction
Journal of the American College of Cardiology Vol. 50, No. 10, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.04.082
More informationCPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea
So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea Coronary Artery Imaging The ideal coronary imaging technology would be capable of identifying not only vessel
More informationEvaluation of stent placement and outcomes with optical coherence tomography
REVIEW Evaluation of stent placement and outcomes with optical coherence tomography Optical coherence tomography (OCT) is an imaging modality based on fiberoptic technology. OCT imaging systems use optical
More informationOptical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting
Chapter 6 Optical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting Shinichi Yoshimura, Masanori Kawasaki, Kiyofumi Yamada, Arihiro Hattori, Kazuhiko Nishigaki, Shinya Minatoguchi
More informationMR Imaging of Atherosclerotic Plaques
MR Imaging of Atherosclerotic Plaques Yeon Hyeon Choe, MD Department of Radiology, Samsung Medical Center, Sungkyunkwan University, Seoul MRI for Carotid Atheroma Excellent tissue contrast (fat, fibrous
More informationMethods and Materials
Methods and Materials Preclinical evaluation of stent healing The study protocol was approved by the responsible authority (Regierung von Oberbayern, AZ 55.2-1-54-2531-29-10) implementing the German Animal
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.01.012 Incomplete
More informationREBEL. Platinum Chromium Coronary Stent System. Patient Information Guide
REBEL Patient Information Guide REBEL PATIENT INFORMATION GUIDE You have recently had a REBEL bare metal stent implanted in the coronary arteries of your heart. The following information is important for
More informationCoronary Paque Imaging by Coronary Angioscopy Comparison with the Other Modalities
Review Angioscopy 2017; 3: 19 27 Coronary Paque Imaging by Coronary Angioscopy Comparison with the Other Modalities Hiroaki Watabe, MD, PhD, * Akira Sato, MD, and Kazutaka Aonuma, MD, PhD. Cardiovascular
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationPlaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC
Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary
More informationRelationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation
Original Article http://dx.doi.org/10.3349/ymj.2013.54.1.41 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(1):41-47, 2013 Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationPrevalence of Coronary Artery Disease: A Tertiary Care Hospital Based Autopsy Study
Article History Received: 03 Feb 2016 Revised: 05 Feb 2016 Accepted: 08 Feb 2016 *Correspondence to: Dr. Alpana Jain Senior demonstrator SMS Medical College, Jaipur, Rajasthan, INDIA. dr.alpana.jain@gmail.com
More informationIN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014
IN-STENT RESTENOSIS K.Boerlage-van Dijk CarVasZ 2014 Definition ISR Angiographic: recurrent diameter stenosis >50% at the stent segment or edges (5-mm segments adjacent to stent) Mehran system morphological
More informationJournal of the American College of Cardiology Vol. 38, No. 1, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01315-8 Coronary
More informationSmooth muscle pharmacology & interventional cardiology
Smooth muscle pharmacology & interventional cardiology By: Pascal Bernatchez!!!!! LAST LECTURE Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure
More informationBioresorbable polymer drug-eluting stents in PCI
EARN 3 FREE CPD POINTS CARDIOVASCULAR Leader in digital CPD for Southern African healthcare professionals The BIOFLOW-V trial, using the Orsiro ultrathin strut stent with biodegradable polymer, showed
More informationClinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD
Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion
More informationCitation Journal of Cardiology Cases (2013), Ltd.; この論文は出版社版でありません 引用の際には出版社版をご確認ご利用ください This is not the publ
Title Pathological analyses of very longimplantation in human coronary arte Author(s) Imai, Masao; Kimura, Takeshi; Tazak Erika; Inoue, Katsumi Citation Journal of Cardiology Cases (01), Issue Date 01-
More informationOCT-Based Diagnosis and Management of STEMI Associated With Intact Fibrous Cap
JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 3, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2012.12.007 CONCEPTS
More informationOCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT
OCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT Substudy Carlo Di Mario, MD Peter Barlis, MD Evelyn Regar, MD Peter Juni, MD Patrick
More informationCoronary Stent Choice in Patients With Diabetes Mellitus
Rome Cardiology Forum 2014 Coronary Stent Choice in Patients With Diabetes Mellitus Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University
More informationHistopathology: Vascular pathology
Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these
More informationPathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD
Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationClinical Characteristics of In-stent Neoatherosclerosis Causing Late Stent Failure
Original Paper J Jpn Coron Assoc 2016; 22: 245-250 Clinical Characteristics of In-stent Neoatherosclerosis Causing Late Stent Failure Koji Isodono, Akiko Matsuo, Atsushi Kyodo, Yumika Tsuji, Akira Sakamoto,
More informationAssessment of vulnerable and unstable carotid atherosclerotic plaques on endarterectomy specimens
2028 Assessment of vulnerable and unstable carotid atherosclerotic plaques on endarterectomy specimens DOINA BUTCOVAN 1,2, VERONICA MOCANU 2, DANA BARAN 2, DIANA CIURESCU 1,3 and GRIGORE TINICA 1,3 1 Department
More informationAssessment of vulnerable plaque by OCT
Assessment of vulnerable plaque by OCT Comparison with histology and possible clinical applications Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Identification of vulnerable
More informationEAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers
EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment
More informationIVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation
IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial
More informationSmooth muscle pharmacology & interventional cardiology
LAST LECTURE Smooth muscle & interventional cardiology By: Pascal Bernatchez Classic Vascular -chronic -systemic Local Vascular -acute -targeted High blood pressure Blood pressure control Atherosclerosis
More informationSMJ Singapore Medical Journal
SMJ Singapore Medical Journal ONLINE FIRST PUBLICATION Online first papers have undergone full scientific review and copyediting, but have not been typeset or proofread. To cite this article, use the DOIs
More informationResults of TROFI II Study. Patrick W. Serruys, MD, PhD. Imperial college, London, UK On behalf of the PI s and the TROFI II investigators
Comparison of the ABSORB TM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience TM ) in Acute ST-Elevation Myocardial Infarction: Results of TROFI II Study.
More informationCoronary Atherosclerosis In Jammu Region - A Random Postmortem Study
ORIGINAL ARTICLE Coronary Atherosclerosis In Jammu Region - A Random Postmortem Study Sindhu Sharma, Jagriti Singh, P. Angmo, Chavi, K.K. Kaul Abstract Atherosclerosis is a complex and common disease contributing
More informationWhat Stent to Use? JASVINDAR SINGH MD, FACC
What Stent to Use? JASVINDAR SINGH MD, FACC ASSOCIATE PROFESSOR OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS DIRECTOR, CARDIAC CATHETERIZATION LAB BARNES-JEWISH HOSPITAL What Stent to Use? Jasvindar
More informationResults of TROFI II Study. Patrick W. Serruys, MD, PhD. Imperial college, London, UK On behalf of the PI s and the TROFI II investigators
Comparison of the ABSORB TM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience TM ) in Acute ST-Elevation Myocardial Infarction: Results of TROFI II Study.
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationBifurcation Stenting: IVUS and OCT Information
Bifurcation Stenting: IVUS and OCT Information Yoshinobu Murasato MD, PhD (New Yukuhashi Hospital) On behalf of J-REVERSE investigators October 14-15, 2011, Lisbon Proximal stent deformation induced by
More informationAssessment of Coronary Plaque Vulnerability with Optical Coherence Tomography
Review Article Acta Cardiol Sin 2014;30:1 9 Assessment of Coronary Plaque Vulnerability with Optical Coherence Tomography Shiro Uemura, Tsunenari Soeda, Yu Sugawara, Tomoya Ueda, Makoto Watanabe and Yoshihiko
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationCoronary Artery Thermography
Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In
More informationStent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study
DOI 10.1007/s10554-012-0032-6 ORIGINAL PAPER Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study Tuomas Lehtinen
More informationThe Latest Experimental Results of Endothelialization with BuMA stent. Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA
The Latest Experimental Results of Endothelialization with BuMA stent Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA In Stent Re -stenosis [%] Neointimal Thickness [mm] A Great Success
More informationStents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.
Stents selection and optimal implantation: sizes, design, deployment Stent classification: Mechanism of expansion - Self-expanding - Balloon expandable Design - Mesh structure - Coil - Slotted tube - Ring
More informationHCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?
HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic
More informationMultimodality Imaging Atlas of Coronary Atherosclerosis
JCC: CRDIOVSCUR IMGING VO. 3, NO. 8, 2010 2010 BY THE MERICN COEGE OF CRDIOOGY FOUNDTION ISSN 0735-1097/$36.00 PUBISHED BY ESEVIER INC. DOI:10.1016/j.jcmg.2010.06.006 IMGING VIGNETTE Multimodality Imaging
More informationQuantification of Coronary Arterial Narrowing at Necropsy in Acute Transmural Myocardial Infarction
Quantification of Coronary Arterial Narrowing at Necropsy in Acute Transmural Myocardial Infarction Analysis and Comparison of Findings in 27 Patients and 22 Controls WILLIAM C. ROBERTS, M.D., AND ANCIL
More informationNoninvasive Coronary Imaging: Plaque Imaging by MDCT
Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation
More information